mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
KU-55933 |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |